Forgyldt dansk biotekbaby i strid om ledelsen

Ejerne i Afyx Therapeutics, tidligere Dermtreat, som blandt andet tæller Novo Seeds, har gennemtrumfet et ledelsesskifte, som sender stifter Jens Hansen ud af direktionen. En beslutning, som nu får ham til at overveje sin fremtid hos selskabet.
Photo: Colourbox
Photo: Colourbox

Afyx Therapeutics, tidligere kendt som Dermtreat, har udmærket sig ved at være målet for en af de største serie A-kapitalrejsninger inden for dansk biotekindustri, men nu er der udbrudt konflikt mellem stifter Jens Hansen og de nye investorer, skriver Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading